Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInvestec Regulatory News (INVP)

Share Price Information for Investec (INVP)

Share Price is delayed by 15 minutes
Get Live Data
623.00    3.00 (0.48%)
Bid:
623.00
Ask:
623.50
Spread: 0.50 (0.08%)
Market Cap: £3.94b
INVP Live PriceLast checked at - London Stock Exchange

Intraday Investec Share Chart

Form 8.5 (EPT/RI)

17 Feb 2025 09:13

Form 8.5 (EPT/RI)

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Name of exempt principal trader:Investec Bank plc
(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeDowlais Group Plc
(c) Name of the party to the offer with which exempt principal trader is connected:Investec is Broker to Dowlais Group Plc
(d) Date dealing undertaken:14th February 2025
(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchases/ sales Total number of securitiesHighest price per unit paid/receivedLowest price per unit paid/received
Ordinary sharesPurchases1,083,26670.569.5
Ordinary sharesSales1,083,26670.569.5

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
N/AN/AN/AN/AN/A

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
N/AN/AN/AN/AN/AN/AN/AN/A

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
N/AN/AN/AN/AN/A

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
N/AN/AN/AN/A

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

Date of disclosure:17th February 2025
Contact name:Priyali Bhattacharjee
Telephone number:+91 9768034903

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
4th Apr 20259:45 amGNWForm 8.5 (EPT/RI)- Dowlais Group plc
4th Apr 20259:33 amGNWForm 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
4th Apr 20259:05 amGNWForm 8.5 (EPT/RI) - NIOX Group plc
4th Apr 20258:59 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
3rd Apr 20259:21 amGNWForm 8.5 (EPT/RI) - Dowlais Group plc
3rd Apr 20259:13 amGNWForm 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
3rd Apr 20259:10 amGNWForm 8.5 (EPT/RI) - De La Rue plc
3rd Apr 20259:06 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
3rd Apr 20259:02 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
2nd Apr 20258:55 amGNWForm 8.5 (EPT/RI) - Dowlais Group plc
2nd Apr 20258:52 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
2nd Apr 20258:49 amGNWForm 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
1st Apr 20259:27 amGNWForm 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
1st Apr 20259:25 amGNWForm 8.5 (EPT/RI) - NIOX Group plc
1st Apr 20259:22 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
1st Apr 20259:19 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
1st Apr 20259:11 amGNWForm 8.5 (EPT/RI) - Dowlais Group plc
31st Mar 20251:00 pmRNSInvestec Ltd Share Incentive Plan: Share Purchases
31st Mar 20259:26 amGNWForm 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
31st Mar 20259:22 amGNWForm 8.5 (EPT/RI) - Aquis Exchange plc
31st Mar 20259:18 amGNWForm 8.5 (EPT/RI) - Alliance Pharma plc
31st Mar 20259:13 amGNWForm 8.5 (EPT/RI) - Dowlais Group plc
31st Mar 20259:10 amGNWForm 8.5 (EPT/RI) - Thruvision Group plc
28th Mar 20253:00 pmRNSDirector/PDMR Shareholding
28th Mar 20258:58 amGNWForm 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
28th Mar 20258:56 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
28th Mar 20258:54 amGNWForm 8.5 (EPT/RI)-Dowlais Group plc
28th Mar 20258:52 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
27th Mar 202512:00 pmRNSDirector/PDMR Shareholding
27th Mar 202511:00 amRNSTransaction in Own Shares
27th Mar 20258:48 amGNWForm 8.5 (EPT/RI)
27th Mar 20258:42 amGNWForm 8.5 (EPT/RI)-NIOX Group plc
27th Mar 20258:40 amGNWForm 8.5 (EPT/RI)-Dowlais Group plc
27th Mar 20257:45 amGNWForm 8.5 (EPT/RI)- Alliance Pharma plc
26th Mar 202512:30 pmRNSDirector/PDMR Shareholding
26th Mar 20258:14 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
26th Mar 20258:12 amGNWForm 8.5 (EPT/RI)-De La Rue plc
26th Mar 20258:09 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
25th Mar 20251:30 pmRNSDirector/PDMR Shareholding
25th Mar 20257:40 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
25th Mar 20257:38 amGNWForm 8.5 (EPT/RI)-Dowlais Group plc
25th Mar 20257:36 amGNWForm 8.5 (EPT/RI)-NIOX Group plc
25th Mar 20257:34 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
24th Mar 20258:25 amGNWForm 8.5 (EPT/RI)-De La Rue plc
24th Mar 20258:23 amGNWForm 8.5 (EPT/RI)-NIOX Group plc
24th Mar 20258:18 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc
24th Mar 20258:13 amGNWForm 8.5 (EPT/RI)-Alliance Pharma plc
21st Mar 20258:00 amRNSPost Stabilisation Notice
21st Mar 20257:37 amGNWForm 8.5 (EPT/RI)-Niox Group plc
21st Mar 20257:07 amGNWForm 8.5 (EPT/RI)-Thruvision Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.